Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
about
Focus on adoptive T cell transfer trials in melanomaAdoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanomaDurable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySpecific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patientsGene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenAdoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimensAdoptive cell transfer: a clinical path to effective cancer immunotherapyAdoptive T cell therapy for cancer in the clinicPhenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcomaThe Evolution of T-cell Therapies for Solid MalignanciesStrategies and Advancements in Harnessing the Immune System for Gastric Cancer ImmunotherapyAdoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlookNovel immunotherapeutic strategies of gastric cancer treatmentTumor infiltrating lymphocytes in ovarian cancerCD4 T-cell immunotherapy for chronic viral infections and cancerCurrent translational and clinical practices in hematopoietic cell and gene therapyAdoptive cell therapies for glioblastomaImproving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationTechnical Considerations for the Generation of Adoptively Transferred T Cells in Cancer ImmunotherapyManufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesIdentification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.Integrative Development of a TLR8 Agonist for Ovarian Cancer ChemoimmunotherapyCD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor.Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.Vaccines against human carcinomas: strategies to improve antitumor immune responses.Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impairedEx vivo expansion of human CD8+ T cells using autologous CD4+ T cell helpFOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesionsTumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cellsTelomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation.Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaSinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies
P2860
Q21328679-B4654413-5731-45AB-B3AE-8B1EC935B3BFQ24548019-7C45689C-A34F-4548-B491-2363266A2D06Q24596055-378751D3-3048-4B1C-9F51-337A39E392B5Q24598792-8045E341-D70B-4DB1-B195-283330CC01B7Q24623215-0B5FAD28-6853-454E-A258-074480B80395Q24644442-F407F72F-850D-4E10-A993-B1106677B3EFQ24644774-903C2041-0408-4A00-BCFD-737622FF4BDCQ24680405-C18FC41B-1E45-40EA-83C8-E2254707E1A0Q24814867-0D7D60F1-AC3D-46C7-8C1E-F37DC5967D57Q26799372-B653A3EA-4393-43F8-8BB6-84EEF806FA21Q26823515-4EDB1130-8001-4669-88FC-3A18EAD93CC4Q27004178-B8710AF4-7FE2-4258-91AC-E11EA1EEE359Q27011232-64B585AA-7343-4394-8244-961F6B3DE2ADQ27021878-E2B2BB4B-4E99-4321-80DC-662937C40E64Q27022957-7FF3B114-3087-4828-A45F-13CED9AB8950Q27024456-6FAA72D1-4E5C-43CA-8AFA-42DF9BB22817Q27030863-411E9D9E-EBDE-483F-AC48-75839116B826Q28068378-7A0D1554-E6C4-443E-9894-02F6B03DB25BQ28073563-C83C71E4-A28B-42D9-826F-0BA4C2F3805DQ28085769-3159F357-3A09-4BE9-9E8E-F62C851780E8Q30252929-3DB00A0C-D433-49D7-868B-8923182A1EE9Q30275792-9456A4B0-0804-4EF5-9C1C-C1F44C715494Q30573747-8C1DC866-6FA6-4AD5-8761-98DF212E4AA2Q33210267-A5488FF2-7672-4759-8930-32EFDC96D570Q33688931-ECC5ABBA-5DC7-40D1-919A-6B62B7DAAA5EQ33734281-E6B4AE44-B5DF-48F3-A81D-5CDE4057A095Q33750205-14710CD3-05F1-4DF9-87F9-B7147CB0872FQ33851742-4A3BE790-0889-4EF5-8794-B6093D9F97EFQ34080914-130FC5F2-A40B-4B99-AB36-7C6A464CEBFDQ34141754-F2D12073-683D-4BF0-A40A-1602025815A5Q34197717-BD4AF042-B711-43B4-A45A-00457B2FEE6FQ34294055-05B3382F-B872-4433-8312-7AB0BBF7B0AFQ34299986-51F73607-142F-452B-BDCA-504092A7DE69Q34307987-9EB4FEB4-EF0F-4903-ACCE-B627B549E2EDQ34314036-242C8D4A-1B16-485C-8FAA-B2127C8D4A83Q34331357-E675AFD0-FCDA-4796-991B-753FA82631E5Q34350259-E860B087-B4DB-491D-BB2C-70D3BB198FF4Q34422330-B4502D1B-C5A1-43B3-9606-038C6E240FB7Q34429991-036785B9-C5A5-4A3D-B657-537E4A8422C2Q34511615-15DA6C8B-5311-4181-AFF4-A3CBAC9E93E1
P2860
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Generation of tumor-infiltrati ...... therapy for melanoma patients
@ast
Generation of tumor-infiltrati ...... therapy for melanoma patients
@en
type
label
Generation of tumor-infiltrati ...... therapy for melanoma patients
@ast
Generation of tumor-infiltrati ...... therapy for melanoma patients
@en
prefLabel
Generation of tumor-infiltrati ...... therapy for melanoma patients
@ast
Generation of tumor-infiltrati ...... therapy for melanoma patients
@en
P2093
P2860
P1476
Generation of tumor-infiltrati ...... therapy for melanoma patients
@en
P2093
John R Wunderlich
Mark E Dudley
Steven A Rosenberg
Thomas E Shelton
P2860
P304
P356
10.1097/00002371-200307000-00005
P577
2003-07-01T00:00:00Z